Greenbrook

IPO

Healthcare

Neurotechnology

Therapeutics

Website: greenbrooktms.com
Type: Public

Ticker: GBNHF · OTC Markets

About

Greenbrook is a Healthcare company.

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare

ConvertibleTotal funding$1.8BApr 2018

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare

Series DTotal funding$1.4BJun 2020

Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare

Series ETotal funding$1.2BJun 2025

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery

Extension RoundTotal funding$1.2BNov 2021

Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics

Corporate RoundTotal funding$1.0BApr 2020

ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences

Series CTotal funding$955.0MSep 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/greenbrook"><img src="https://indexed.vc/api/badge/company/greenbrook" alt="Greenbrook on Indexed.vc" width="260" height="76" /></a>